Weight loss jabs like Ozempic can cut the risk of heart attacks or strokes by a fifth ... of the amount of weight they lose while on the drug, researchers said, suggesting the treatment could ...
The five-year study explored if the drug sold under the brand names Wegovy, Ozempic and Rybelsus could reduce the risk of ...
Anti-obesity jabs could reduce the risk of heart attacks, strokes or heart failure in obese people regardless of the amount of weight they lose while on the drug, researchers have found.
Find your bookmarks in your Independent Premium section, under my profile Weight loss jabs like Ozempic can cut the risk of heart attacks or strokes ... lose while on the drug, researchers said ...
Its famous as a weight loss jab but effects are much more wide-ranging (Picture: Getty/Metro.co.uk) Ozempic could ...
a drug used to treat obesity, significantly reduces the risk of heart attacks and strokes, regardless of the amount of weight lost while on the medication. Semaglutide, marketed under the brand ...
The drug Wegovy uses an active ingredient called Semaglutide, which is part of a growing class of GLP-1 drugs that make ...
Anti-obesity injections could lower the chances of serious heart disease in overweight individuals, regardless of their weight loss while on the medication ... a lower risk of heart attack ...
A recent study found that weight loss jabs can prevent heart attacks and strokes. The study found that the weight loss drug ...
Obesity jabs could cut the risk of heart attacks and strokes in people even if they fail to lose much weight, according to an analysis of a study funded by a drug manufacturer. Researchers looked ...
An anti-obesity drug could have additional health benefits including reducing the risk of heart attacks and strokes a new study has revealed. A five-year study was carried out by a team led ...
A weight loss injection ... taking the medication semaglutide, the active ingredient in brands including Wegovy and Ozempic, had a 20 per cent lower risk of heart attack, stroke or death due ...